Latest National Institute of Health Stories
~Company Recognized as Notable Recipient of SBIR Grants CHARLOTTESVILLE, Va., June 20, 2014 /PRNewswire/ -- HemoShear, LLC, the human disease biology company, today announced that
$3 Million NIH Grant to Fund Effort to Rescue Tissue That Would be Destroyed Charlottesville, Va.
NASA astronaut Michael Hopkins met Stephen I. Katz, director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases on Tuesday at National Institutes of Health (NIH) campus in Bethesda, Maryland
SANTA MONICA, Calif., June 6, 2014 /PRNewswire/ -- Kite Pharma, Inc., a clinical-stage biotechnology company focused on developing engineered autologous T cell therapy (eACT(TM)) products for
Collaboration among Experts in Geriatric Research and Care, Older Adults and Caregivers Aims to Stem Debilitating Problem Affecting One in Three Older People WASHINGTON, June 4, 2014
AADi Initiates NIH Funded Clinical Trial for Patients with Bladder Cancer PACIFIC PALISADES, Calif., May 20, 2014 /PRNewswire/ -- AADi, LLC, a clinical stage biopharmaceutical company
SAN DIEGO, May 13, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc.
Therapist Researcher Al R Zia of Ann Arbor, MI produced amazing results in his first batch of clinical trials with Parkinson's Disease ended May 1st, 2014 via CranioSacral Integrative therapy.
Newly published findings by nationally recognized pediatric cardiologist Dr.
Federal agency responsible for ensuring clinical trials are properly conducted only opened one investigation in all of 2013 and other enforcement activity has significantly declined in recent